Biotech
Pivot Bio
Pivot Bio raises $430M Series D at $2B valuation
Berkeley, CAJune 29, 20211 min read
Total Raised
$430M
Valuation
$2B
Latest Round
Series D
Employees
250+
Pivot Bio: Series D Funding Round
Pivot Bio has successfully raised $430M in Series D funding, reaching a valuation of $2B.
Company Overview
Nitrogen-producing microbes for agriculture
Funding Details
The Series D round was led by DCVC, with participation from Temasek.
Company Information
- Headquarters: Berkeley, CA
- Founded: 2011
- Employees: 250+
- Category: Biotech
Investment
Pivot Bio plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- DCVC: Verified investor in Series D
- Temasek: Verified investor in Series D
Company Info
Headquarters
Berkeley, CA
Founded
2011
Team Size
250+
Last Round
$430M(Jun 2021)
Investors (2)
D
DCVCLeadLead Investor
Verified investor in Series D
T
TemasekInvestor
Verified investor in Series D
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free